CRP and metabolic syndrome: Increased microbial translocation is also associated with dyslipidemia, insulin resistance, and increased risk of cardiovascular events in both HIV-infected and uninfected individuals [43–45], and persistently elevated CRP and other inflammation biomarkers predispose to fatal and non-fatal cardiovascular events [46, 47].